BlackRock Group’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$5.31M Buy
103,956
+8,889
+9% +$454K ﹤0.01% 1149
2016
Q3
$4.38M Buy
95,067
+31,517
+50% +$1.45M ﹤0.01% 1166
2016
Q2
$1.92M Buy
63,550
+56,642
+820% +$1.71M ﹤0.01% 1575
2016
Q1
$222K Buy
6,908
+2,875
+71% +$92.4K ﹤0.01% 2521
2015
Q4
$235K Sell
4,033
-104
-3% -$6.06K ﹤0.01% 2464
2015
Q3
$175K Buy
4,137
+830
+25% +$35.1K ﹤0.01% 2552
2015
Q2
$241K Buy
+3,307
New +$241K ﹤0.01% 2511
2015
Q1
Sell
-18,562
Closed -$679K 2871
2014
Q4
$679K Buy
18,562
+300
+2% +$11K ﹤0.01% 2097
2014
Q3
$576K Buy
+18,262
New +$576K ﹤0.01% 2090